Structure announces positive results from oral GLP-1 receptor agonist gsbr-1290
Structure Therapeutics has announced positive results from the Phase 1b multiple ascending dose (MAD) study of its highly selective oral...
top of page
Browse by category
Search
Browse by tag
bottom of page